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Receptor for activated C-kinase 1 (RACK1) is involved
in a multitude of cellular actions regulating cell develop-
ment, growth, movement, and apoptosis. RACK1 is an
important scaffolding protein active in several different
signaling pathways. RACK1 has recently been linked to
tumor growth, found to be up-regulated in breast, mela-
noma, lung, colon, and oral squamous cancers.
Activating Ras mutations are involved in a significant
fraction of human tumors. A suppressor screen using a
retroviral mouse fibroblast cDNA library was performed
to identify novel factors in Ras-mediated transformation.
We identified a potent inhibitor of Ras-mediated mor-
phological transformation encoded by a truncated ver-
sion of the receptor for activated C-kinase (RACK1) [1].
The truncated protein, designated RACK1ΔWD1, lacked
the N-terminal 49 amino acids encoding the first of the
seven WD40 repeats in RACK1. RACK1ΔWD1expres-
sion restored contact inhibition, stress fiber formation,
and reduced ERK phosphorylation in Ki-Ras trans-
formed NIH 3T3 cells. We demonstrate that truncated
RACK1 is involved in complexes consisting of wild-type
RACK1 and protein kinase C isoforms a, I, and δ,
compromising the transduction of an activated Ras sig-
nal to the Raf-MEK-ERK pathway. Notably, 12-O-tetra-
decanoyl-13-phorbol acetate (TPA) mediated
intracellular translocation of RACK1-interacting PKC a
and δ was abrogated in RACK1ΔWD1-expressing cells.
Our data support a model where RACK1 acts as a key
factor in Ki-Ras-mediated morphological transformation.
By use of co-immunoprecipitation and co-localization
analysis in mammalian cells, we found RACK1 to exist
in a complex with Ki-Ras and B-Raf. In cells expressing
both RACK1and a RACK1 mutant, RACK1ΔWD1, the
mutant protein was also present in this complex. Sur-
face Plasmon resonance (SPR) technology analysis con-
firmed these interactions in vitro and explained the
selective binding of RACK1-Ki-Ras-GTP relative to
RACK1-Ki-Ras-GDP with a 10-fold increase in the bind-
ing strength and further proved the mutant Ki-Ras
(G12C) to increase this interaction 16-fold. Interestingly,
RACK1ΔWD1 bound significantly stronger to Ki-Ras-
GTP than RACK1 presenting a 5-fold increase in the
equilibrium dissociation constant. This confirms that
RACK1ΔWD1 may function as a competitor of RACK1
interactions. SPR experiments demonstrated that B-Raf
binds to Ki-Ras forming a complex with RACK1. There-
fore, our present findings establish a direct physical
involvement of RACK1 as a scaffold protein in regulat-
ing the Ras-Raf-Mek-Erk signaling cascade essential in
cancer development.
RACK1 mRNA and protein expression in papillary
thyroid carcinomas were studied using RT-PCR and
immunohistochemistry respectively. Both at the mRNA
and protein level, RACK1 was found to be highly
expressed in all tumour cells while Ki-Ras was found to
be unchanged and B-Raf barely detectable. Sequencing
analysis detected no mutations in RACK1 or Ki-Ras, but
60 % of the patients presented the B-Raf single nucleo-
tide substitution T1799A (codon V600E) which is
reported frequently in thyroid cancers.
Our studies places RACK1 as an important regulator
of Ras-mediated signal transduction forming “communi-
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cation-hub” consisting of activated Ras-Raf-PKC-
RACK1. RACK1expression is significantly upregulated
in thyroid papillary carcinomas and a mutated form of
RACK1 negatively interferes with Ras signalling.
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